HEATHER ROSDAIL: Open Payments
NPI 1407578537 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,758 in 88 payments from 19 companies in 2025. Trend: 2023 $2,044 · 2024 $2,163 · 2025 $3,758
Food & beverage: $3,758
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 15 | $709 |
| Neurocrine BioSciences, Inc. | 6 | $560 |
| Alkermes, Inc. | 16 | $486 |
| Teva Pharmaceuticals USA, Inc. | 3 | $283 |
| E.R. Squibb & Sons, L.L.C. | 4 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $194 |
| ABBVIE INC. | 11 | $187 |
| Collegium Pharmaceutical, Inc. | 4 | $177 |
| SPR Therapeutics, Inc | 1 | $133 |
| Incyte Corporation | 1 | $131 |
Products named: SPRAVATO, INGREZZA, ARISTADA, COBENFY, CAPLYTA, VRAYLAR, Jornay PM, SPRINT PNS System.
Industry payments across CA — which companies pay providers there.
